Patents Assigned to Eu Sol Biotech Co., Ltd.
  • Modified acidic fibroblast growth factors and composition thereof
    Patent number: 9567385
    Abstract: The present invention provides acidic fibroblast growth factor (aFGF) composition, comprising: (i) aFGF of SEQ ID NO: 1, (ii) aFGF of SEQ ID NO: 1 having an N-terminal phosphogluconoylation, (iii) aFGF of SEQ ID NO: 1 having an N-terminal gluconoylation, (iv) aFGF of SEQ ID NO: 2 and (v) aFGF of SEQ ID NO: 3, or a combination thereof. Also provided is a modified acidic fibroblast growth factor (aFGF) which has an N-terminal phosphogluconoylation or gluconoylation.
    Type: Grant
    Filed: October 7, 2014
    Date of Patent: February 14, 2017
    Assignee: EU SOL BIOTECH CO., LTD.
    Inventor: Ya-Hui Lee
  • Method for repairing neurodegeneration
    Patent number: 9198953
    Abstract: The present invention provides for treating neurodegeneration caused by nerve compression syndrome or entrapment neuropathy comprising administering human acidic fibroblast growth factor (aFGF), fibrinogen, aprotinin and divalent calcium ions to a subject in need thereof.
    Type: Grant
    Filed: August 13, 2010
    Date of Patent: December 1, 2015
    Assignee: Eu Sol Biotech Co., Ltd.
    Inventors: Henrich Cheng, Ming-Jei Lo, Yee-Chiang Liu
  • METHOD FOR TREATING BRAIN INJURY OR STROKE
    Publication number: 20140155816
    Abstract: The present invention provides a method for treating brain injury or stroke in a subject in need thereof, comprising implanting a microdialysis probe into the injury or insult core of the subject and perfusing the probe with an oncotic agent dissolved in a physiologically acceptable buffer, wherein the microdialysis probe comprises a dialysis membrane with a molecular weight cutoff less than the molecular weight of the oncotic agent.
    Type: Application
    Filed: October 8, 2013
    Publication date: June 5, 2014
    Applicant: EU SOL Biotech Co., Ltd.
    Inventors: HENRICH CHENG, MAY-JYWAN TSAI, SHIANG-SUO HUANG, SHIH-LING HUANG
  • Modified peptide of human acidic fibroblast growth factor
    Patent number: 7956033
    Abstract: An modified peptide of human acidic fibroblast growth factor (aFGF), comprising a native human aFGF shortened by a deletion of a deletion of 20 amino acids from N-terminal of the native human aFGF, and an addition of Alanine (Ala) before the shortened native aFGF is provided.
    Type: Grant
    Filed: June 10, 2009
    Date of Patent: June 7, 2011
    Assignee: Eu Sol Biotech Co., Ltd.
    Inventors: Henrich Cheng, Wen-Chun Kuo
  • METHOD FOR REPAIRING NEURODEGENERATION
    Publication number: 20110039774
    Abstract: The present invention provides for treating neurodegeneration caused by nerve compression syndrome or entrapment neuropathy comprising administering human acidic fibroblast growth factor (aFGF), fibrinogen, aprotinin and divalent calcium ions to a subject in need thereof.
    Type: Application
    Filed: August 13, 2010
    Publication date: February 17, 2011
    Applicant: EU SOL BIOTECH CO., LTD.
    Inventors: HENRICH CHENG, MING-JEI LO, YEE-CHIANG LIU
  • MODIFIED PEPTIDE OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
    Publication number: 20090305988
    Abstract: An modified peptide of human acidic fibroblast growth factor (aFGF), comprising a native human aFGF shortened by a deletion of a deletion of 20 amino acids from N-terminal of the native human aFGF, and an addition of alanine (Ala) before the shortened native aFGF is provided.
    Type: Application
    Filed: June 10, 2009
    Publication date: December 10, 2009
    Applicant: Eu Sol Biotech Co., Ltd.
    Inventors: Henrich Cheng, Wen-Chun Kuo